Clinical Trial: Exploring the Clinical Application Value of cfDNA Methylation Liquid Biopsy in Patients with Organ Injury Induced by Radiotherapy Combined Therapy for Non-Small Cell Lung Cancer (China)

Posted On: 2026-10-21

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploring the Clinical Application Value of cfDNA Methylation Liquid Biopsy in Patients with Organ Injury Induced by Radiotherapy Combined Therapy for Non-Small Cell Lung Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134770

Registration Time: 2026/10/20

Type: Observational study

Primary Sponsor: Affiliated Cancer Hospital of Shandong First Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=306448

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Exploring the Clinical Application Value of cfDNA Methylation Liquid Biopsy in Patients with Organ Injury Induced by Radiotherapy Combined Therapy for Non-Small Cell Lung Cancer (China)